| Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants (NCT07363837) | Shanghai Institute Of Biological Products | 2026-01-15 |
| Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above (NCT07327398) | Shanghai Institute Of Biological Products | 2026-01-07 |
| Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo (NCT07253675) | Shanghai Institute Of Biological Products | 2025-12-31 |
| A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above (NCT07302256) | Shanghai Institute Of Biological Products | 2025-12-16 |
| A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects. (NCT07205198) | Shanghai Institute Of Biological Products | 2025-10-31 |
| A Clinical Trial of SIBP-A16 Injection in Healthy Adults (NCT07106918) | Shanghai Institute Of Biological Products | 2025-08-17 |
| A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients (NCT06985368) | Shanghai Institute Of Biological Products | 2025-06-16 |
| A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients (NCT06990464) | Shanghai Institute Of Biological Products | 2025-06-11 |
| A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals (NCT06932523) | Shanghai Institute Of Biological Products | 2025-04-04 |
| A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine (NCT06771479) | Shanghai Institute Of Biological Products | 2025-01-22 |
| Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma (NCT06194656) | Shanghai Institute Of Biological Products | 2024-09-27 |
| A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. (NCT06512116) | Shanghai Institute Of Biological Products | 2024-07-23 |
| Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months (NCT06399003) | Shanghai Institute Of Biological Products | 2024-06-28 |
| A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. (NCT06298058) | Shanghai Institute Of Biological Products | 2024-05-09 |
| A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. (NCT06342349) | Shanghai Institute Of Biological Products | 2024-03-30 |
| A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. (NCT06298071) | Shanghai Institute Of Biological Products | 2023-03-03 |
| A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster (NCT05492591) | Shanghai Institute Of Biological Products | 2022-10-11 |
| A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia (NCT05302388) | Shanghai Institute Of Biological Products | 2022-04-11 |
| Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old (NCT05158777) | Shanghai Institute Of Biological Products | 2022-02-13 |
| Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live (NCT05161845) | Shanghai Institute Of Biological Products | 2021-12-23 |
| Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years (NCT05138705) | Shanghai Institute Of Biological Products | 2021-12-14 |
| A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors. (NCT05203601) | Shanghai Institute Of Biological Products | 2020-11-26 |
| A Clinical Trial of PEGIFNα1b in Chinese Healthy Adults (NCT05639803) | Shanghai Institute Of Biological Products | 2020-07-07 |
| A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer (NCT05318443) | Shanghai Institute Of Biological Products | 2020-04-17 |
| Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (NCT04363359) | Shanghai Institute Of Biological Products | 2020-01-15 |
| A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects (NCT04135898) | Shanghai Institute Of Biological Products | 2019-10-23 |
| A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL (NCT04361279) | Shanghai Institute Of Biological Products | 2019-07-25 |
| A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer (NCT03989037) | Shanghai Institute Of Biological Products | 2019-06-27 |
| A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years (NCT04072497) | Shanghai Institute Of Biological Products | 2018-11-20 |
| A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03755427) | Shanghai Institute Of Biological Products | 2018-11-10 |
| A Clinical Trial of A Quadrivalent Influenza Vaccine (NCT03744104) | Shanghai Institute Of Biological Products | 2018-10-11 |
| A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03369808) | Shanghai Institute Of Biological Products | 2017-12-29 |
| Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants (NCT01494740) | Shanghai Institute Of Biological Products | 2009-12-01 |
| The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine (NCT01336166) | Shanghai Institute Of Biological Products | 2009-07-01 |